Nasal spray used for allergies recalled in Canada

A nasal spray that is used to treat allergies is being recalled in Canada.

Apo-Mometasone treats allergy symptoms in children, sinusitis in patients 12 and older, and nasal polyps in adults.

Some lots of the spray may be contaminated with an infectious bacteria known as Burkholderia cepacia complex (Bcc).

Symptoms of infection from the bacteria may manifest in the forms of fever, weight loss, pain in the stomach, chest, muscles or joints and can cause headaches.

“Bcc is a group of bacteria that poses a low medical risk to most healthy people,” reads the recall notice.

“However, children, those with chronic lung diseases, people who are pregnant, seniors and those with a weakened immune system may be at a higher risk of illness.

Two lots of the spray made by Apotex are being recalled, with expiration dates of September and October 2025.

Recalled lots

The lot numbers themselves are TX5343 and TZ2586, which can be found on the side of the bottle.

Anyone in possession of the affected product should not use it and instead return it to a pharmacy where it can be properly disposed of.

If you have used it, contact a healthcare professional immediately.

Health Canada says it is monitoring the company’s recall.